Chordia Therapeutics Inc.
190A
Rank in Stocks
#25959
Chordia Therapeutics Inc., a biotech company, engages in research and... Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
Share Price
$0.28765011
Last synced: 2026-11-13
Market Cap
$22.14M
Change (1 day)
2.10%
Change (1 year)
-56.98%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Chordia Therapeutics Inc. (190A)
Category
Healthcare
Operating Margin for Chordia Therapeutics Inc. (190A)
Operating Margin as of November 2026 TTM: 0.00%
According to Chordia Therapeutics Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Chordia Therapeutics Inc. from 2021 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | 8.48% | 0.00% |
| 2022 | 0.00% | -100.00% |
| 2021 | -73.46% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -195.39% | - |
US
|
|
| 33.87% | - |
US
|
|
| -116.04% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Chordia Therapeutics Inc.'s operating margin
What was Chordia Therapeutics Inc.'s operating margin in 2025?
In 2025, Chordia Therapeutics Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Chordia Therapeutics Inc.'s operating margin changed since 2021?
From 2021 to 2025, Chordia Therapeutics Inc.'s operating margin was highest in 2023 (8.48%) and lowest in 2021 (-73.46%).
How does Chordia Therapeutics Inc.'s operating margin compare with similar companies?
Chordia Therapeutics Inc.'s operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.